FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.
TiGenix NV (Euronext Brussels and Nasdaq: TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, today announced that the first patient has been enrolled and treated in its Phase Ib/IIa clinical trial for Cx611 (SEPCELL) in the treatment of severe sepsis in community-acquired pneumonia (CAP). read more
Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it increased its market share in Belgium by 0.97% to 45.84% compared to 2015, placing it ahead of Bayer and Merck. The Company also achieved an increase in sales of 4.23%. read more
Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology, today announced its cash & cash equivalents and liquid investments position and its highlights from the fourth quarter of 2016. read more
Confocal microscopy, which enables scientists to construct 3D representations of objects in the range of hundreds of nanometer, has been the workhorse and method of choice for imaging for decades now and has revolutionized our view of biology and life sciences. Scientists at VIB have taken the potential of confocal microscopy across the diffraction barrier – using innovative software-based image analysis tools. In the past, it was believed that the laws of physics make it impossible for classical confocal microscopy to resolve anything smaller than 200 nanometers. This new, patented methodology now makes this possible and will be further developed through a collaboration between VIB and German microscopy leader Zeiss. read more
ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that Dr George Gunn joined its board of directors. read more
Brain injuries, dementia and other neurological problems are often noticed too late. The damage is irrevocable. ADX Neurosciences S.A. is committed to developing biomarkers that can detect, with a simple blood test, neurodegeneration in an early stage. The Flemish government supports the innovative research of this biotech company. read more
• Primary objective of safety and tolerability met • In the three highest dose groups, 100% of patients achieved a 75% or greater reduction in disease activity compared to 0% for placebo • The onset of clinical effect was rapid and sustained throughout the study read more
GENTICEL (Euronext Paris and Brussels: FR0011790542 - GTCL), a French biotechnology company today announces its schedule for the publication of financial information in 2017 and the date of its 2017 Annual General Meeting. read more
Het digimeter-team peilde de voorbije maanden opnieuw naar het mediagebruik in Vlaanderen. Bijna alle Vlamingen blijken ondertussen over een of meerdere toestellen te beschikken om altijd en overal online te zijn: slechts 6% zegt thuis geen enkel slim digitaal toestel te hebben. Iedereen digitaal dus? Zo eenvoudig is het niet. Niet iedereen blijkt immers met dezelfde snelheid mee te surfen op de digitale golf. Enerzijds geeft een op drie van de Vlamingen aan afhankelijk te zijn van hun smartphone of sociale media (13% is zelfs digibees). Anderzijds slaagt 11% er niet in digitale toepassingen vlot te gebruiken. read more
Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), and Aratana Therapeutics, Inc. (NASDAQ: PETX) have announced veterinarians have a new targeted tool for the management of pain and inflammation associated with canine osteoarthritis (OA). Galliprant® (grapiprant tablets), a first-in-class piprant, is now available to veterinarians for once-daily use in dogs with OA. Galliprant can be used in patients as young as 9 months, weighing 8 pounds or more, and most dogs can be dosed once a day with a whole or half tablet. read more